These medications are currently being advised for adults with: Type 2 diabetes, especially uncontrolled sugar Those with cardiovascular risk Obesity (individuals with a BMI 30) Overweight (individuals with a BMI 27) with related health conditions such as high blood pressure, sleep apnea, or prediabetes That said, not all GLP-1s carry the same approvals
other weekly agents have different thresholds
Conclusions Consistent with clinical trials, real-world tirzepatide treatment was associated with greater 6-month weight reduction and more frequent achievement of weight-reduction targets and improvements in select cardiometabolic parameters than semaglutide among adults with obesity without diabetes
Faycurry, RD says, "Protein needs vary based on weight, activity level, and individual factors
Approaching this conversation with realistic expectations and understanding of the current evidence will facilitate shared decision-making
Potential Liver or Kidney Issues: However, a dark brown or cola-coloured urine can also be a sign of a much more serious underlying condition
